Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Zuellig Pharma
Entity

Zuellig Pharma

Tracked across 1 events · 7 articles · First seen Feb 09, 2026 · Last active Feb 09, 2026

Sentiment
40
Attention
2
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 40
Business
Zuellig Pharma Acquires Zam-Buk, Vapex Brands
Zuellig Pharma acquired the rights to the Zam-Buk and Vapex consumer healthcare brands, strengthening its consumer healthcare portfolio and expanding its presence in Asia. This acquisition is a significant growth milestone for the company.
Feb 09, 2026 · 7 articles
Relationships (1)
John Graham CEO ↔ Zuellig Pharma John Graham is the CEO of Zuellig Pharma, leading its strategic initiatives.
NEWSDESK
Track Zuellig Pharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.